🚨Recently published in #CardioOncology Assessing double product derived from stress echocardiography as a prognostic indicator of major adverse cardiac events in patients with breast cancer treated with radiotherapy📊🔍 ➡️doi.org/prx4

165 HCC s/p ablation + LT. LIRADS-TRA vs Explant - high SP (95%) but low SN (19%) for viable HCC. IRR for TRA was higher in CT cohort, TRA agreement w/ explant was higher in MRI cohort. Congrats ANURADHA SHENOY-BHANGLE, AmmarSarwarIRad, and team BIDMC Vascular & Interventional Radiology. More 👉 pubmed.ncbi.nlm.nih.gov/40413459/

🚨Recently published in #CardioOncology Importance of E/e’ and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study🫀 ➡️doi.org/psdm

🚨Recently published in #CardioOncology Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study🔍 #OpenAccess #CardiovascularHealth ➡️doi.org/psdp

🚨Recently published in #CardioOncology Primary cardiac sarcoma: insights from two decades of multimodal management at LMU Munich🫀 #OpenAccess #CardiovascularHealth ➡️doi.org/ps96

🚨Recently published in #CardioOncology Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis🔍 #OpenAccess #CardiovascularHealth ➡️doi.org/pvcf

New work by Chris Hoeger in our #CardioOnc program BIDMC CVI investigating cardiotoxicity of the commonly used Doxil/Avastin regimen rdcu.be/euyN6 Huge thanks to collaborators Sarju Ganatra, MD, FACC DrJE-Salem and BI team Nathalie Rosas, Reese Pinto, Rishi Wadhera, MD MPP, Meghan Shea

Check out our publication in #CardioOncology. Atrial fibrillation/flutter in stem cell transplant patients. Prevalence, association with outcomes, and impact on healthcare resource-utilization/readmissions. Joshua Mitchell Ahmed Teebi, MD MPH🗝️ rdcu.be/euXbx

ΔSUVmax is a promising standalone prognostic marker or combination partner of #DeauvilleScore in the early risk stratification and response assessment of #HodgkinLymphoma. #lymsm cancerimagingjournal.biomedcentral.com/articles/10.11…

🚨Recently published in #CardioOncology In CONCEPT, low hsTroponin I predicted low CVAE risk during carfilzomib-based therapy in newly diagnosed multiple myeloma, whilst elevated NT-proBNP was common 🫀 ➡️Read more: doi.org/pvcg

🚨Recently published in #CardioOncology Atrial fibrillation is associated with increased in-hospitality mortality during Chimeric Antigen Receptor T-cell therapy hospitalizations: a retrospective cohort study in the United States 🫀 ➡️doi.org/pvch

🚨Recently published in #CardioOncology Atrial fibrillation or flutter in patients undergoing stem cell transplantation, in-hospital and post-discharge outcomes in a large nationwide sample across the United States🔍 #OpenAccess #CardiovascularHealth 👉doi.org/pvw8

Our study published in Journal of Hematology & Oncology : Chen, Y., Huo, D., Meng, Y. et al. BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis. J Hematol Oncol 18, 67 (2025). doi.org/10.1186/s13045… #BRD4 #erythropoiesis github.com/HyacinthMeng/B…

🚨Recently published in #CardioOncology Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy🫀 #OpenAccess #CardiovascularHealth #BreastCancer Katelyn Atkins, MD, PHD 👉doi.org/pvxc

🚨Recently published in #CardioOncology QT STAR: concomitant QTc-prolonging medication use among patients with HR+/HER2− metastatic breast cancer receiving a CDK4/6 inhibitor in first line💊 #OpenAccess #CardiovascularHealth Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC 👉doi.org/pv69

🚨Recently published in #CardioOncology Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis📝 #OpenAccess #CardiovascularHealth 👉doi.org/pv7b

1/6📢 Excited to share our new publication in BMC (BMC Cardio-Oncology): We explored #CardioMEMS 📡 for heart failure management in cancer patients—a group often overlooked in trials. Grateful to Cezar Iliescu for his mentorship.📖 rdcu.be/ewUQd #CardioOnc

🚨Recently published in #CardioOncology Prevention and treatment of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis of randomized controlled trials🫀 #OpenAcess #CardiovascularHealth 👉doi.org/pv7c

🚨Recently published in #CardioOncology CardioMEMS guided heart failure management in cardio-oncology patients: a tertiary care cancer center experience🫀 #OpenAccess #CardiovascularHealth Abdelrahman Ali International Cardio-Oncology Society 👉doi.org/pw4j

🚨Recently published in #CardioOncology The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors🔍 #OpenAccess International Cardio-Oncology Society 👉doi.org/pw4k